N/A
Completed N=4
A Study of Dental Implants Coated With Bone Morphogenetic Protein
Alveolar Ridge Abnormality
Source: ClinicalTrials.gov NCT00422279 ↗
Enrolled (actual)
4
Serious AEs
0.0%
Results posted
May 2015
Primary outcomePrimary: Primary Endpoint Was to Assess Implant Stability of the Implants( 4 Patients in Two Groups With a Total of 8 Implants) at Baseline and After 3 Months of Submerged Healing and After 6 Months of Prosthetic Loading — 4; 4; 4; 3 implants
Summary
The purpose of the study is to evaluate implant stability and stimulate clinically relevant horizontal and vertical new bone formation around Nobel Biocare's Bone Inductive Implant.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Primary Endpoint Was to Assess Implant Stability of the Implants( 4 Patients in Two Groups With a Total of 8 Implants) at Baseline and After 3 Months of Submerged Healing and After 6 Months of Prosthetic Loading |
4; 4; 4; 3; 4; 3 | — |
| SECONDARY Number of Participants Showing Bone Growth With rhBMP-2 (15 and 30 µg Per Implant) |
0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Above the age of 18 years.
- 2 teeth or more are missing either upper/lower jaw (Treatment Gp 1)
- 2 or more teeth require extraction either upper/lower jaw.(Treatment Gp 2)
Exclusion Criteria
- Medical risk patients
- Smoking.
Data sourced from ClinicalTrials.gov (NCT00422279). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.